Professor of Medicine, Director of Fellowship Program in Hematology at Division of Hematology, Norris Comprehensive Cancer Center(Los Angeles, CA, USA).
Professor Liebman is on the forefront of research in thrombotic and hemorrhagic disorders. He and his team are currently studying the genetic risk factors responsible for thrombotic diseases, including venous thrombosis, pulmonary embolism, arterial thrombosis and thrombosis associated with cancer chemotherapy. He has also been the principle investigator on a number of clinical trials in the management of immune thrombocytopenia.
Professor Liebman has authored or co-authored over 100 medical articles and chapters and has led well over a hundred lectures across the USA, South America, Europe and Japan on a variety of medical topics.
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.
Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.